Contract manufacturing
Commercial-scale handling of pharmaceutical materials from cultivators to buyers.

A dedicated, licensed cGMP processing facility for medical cannabis, built to EU-GMP standards.
Partner cultivationOur cultivation partners are licenced, audited and approved to ensure we provide only the best South Africa has to offer.Commercial-scale handling of pharmaceutical materials from cultivators to buyers.
Packing and co-packing according to client specifications.
Batch and testing documentation prepared for regulated markets, supported by qualified pharmaceutical logistics partners.
High-volume pre-roll production to client specification, in child-resistant tubes, under the same batch control as everything else in the building.
Inbound handling of material from outside South Africa under permit, for manufacturing here and onward supply.
Extraction of cannabis actives and downstream formulation into finished dosage formats.

A ring, a methyl group, a chain. From cultivation to manufacturing, nothing is left to chance.

Dedicated third-party model
We are a manufacturer, not a cultivator. We manage your product.
Engineered for throughput
Layout and equipment are sized for high-volume B2B contracts rather than boutique batches.
Compliance built in from day one
Robust QMS system designed for export scrutiny.
Regional cost advantage
Local operating costs allow competitive manufacturing rates without compromising standard.
We would rather answer a hard question now than at the shipping stage.
Green Pharma welcomes discussions with licensed cannabis producers and prospective supply partners.
Potential suppliers are assessed based on their licensing and compliance status, product quality, specifications, testing, traceability, available volumes and intended market requirements.
Yes. This is one of the primary reasons Green Pharma was established.
GACP provides the foundation for compliant cultivation and handling of medicinal cannabis, but regulated pharmaceutical markets can require additional GMP manufacturing, quality, testing, packaging and documentation controls before a product can progress through the pharmaceutical supply chain.
Green Pharma was specifically established to provide this critical GMP step, helping bridge the gap between licensed GACP production and the requirements of regulated pharmaceutical markets.
Yes. Green Pharma operates as a SAHPRA-licensed cGMP medicinal cannabis manufacturing facility in South Africa.
Our facility was purpose-built around pharmaceutical quality systems and GMP principles, with a particular focus on providing third-party contract manufacturing and packaging services to the medicinal cannabis industry.
All activities are conducted within Green Pharma’s approved licence scope and applicable regulatory requirements.
Green Pharma currently provides specialised cGMP manufacturing and packaging services within our approved regulatory scope, including primary and secondary packaging, weighing, labelling, controlled product handling, quality management and associated batch documentation.
Green Pharma is also entering its next phase of development. We are progressing plans to significantly expand our facility and broaden our future manufacturing capabilities to include additional processing activities such as extraction, formulation and other value-added pharmaceutical manufacturing services.
These additional capabilities will be introduced subject to the necessary facility development, validation and regulatory approvals.
Green Pharma is currently progressing its EU GMP certification pathway.
Following the successful completion of our South African licensing process, EU GMP represents an important next stage in the development of our facility and international manufacturing capabilities.
Until this certification process has been successfully completed, Green Pharma does not represent itself as EU GMP certified.
The materials, required volumes, desired format, and intended market. It all starts with one inquiry.